
Free Daily Podcast Summary
by Max Brennan - Biotech HeadHunter
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Get ready for an immersive experience into the world of biotech with The BioHub.
The most recent episodes — sign up to get AI-powered summaries of each one.
In this episode of The BioHub by Avetix, I’m joined by Edward van Wezel, Managing Partner and Co-Founder of BioGeneration Ventures.Edward shares his journey into venture capital and the story behind building BGV into one of Europe’s leading early-stage life sciences investors. We discuss how he evaluates companies at the earliest stages, what he looks for in founders and leadership teams, and the lessons behind standout investments such as Acerta Pharma.We also explore the evolution of the European biotech ecosystem, the challenges of fundraising and company creation, and what Edward believes Europe needs to do to build more globally competitive biotech companies.
Today, I’m joined by Jo Lane, a senior People and HR leader currently working with COMPASS Pathways, where she plays a key role in supporting the organisation and its people as the company continues to develop and grow.Jo has built an impressive career across the life sciences and healthcare sectors, with senior HR and organisational development roles at COMPASS Pathways, Ipsen and IQVIA. Her experience spans people strategy, organisational development, talent, leadership, change and building high-performing teams across global organisations.Today, we’re going to talk about Jo’s journey through HR and into biotech, her experience supporting companies through periods of growth and transformation, and what she’s learned about building the right culture and teams along the way. We’ll also explore leadership, talent retention and how the role of HR continues to evolve within the biotech industry.
In this episode of The BioHub by Avetix, I’m joined by Tony Estrada, Co-Founder and CEO of Tenvie Therapeutics.Tony shares his journey from Genentech and Denali Therapeutics to founding Tenvie, and why he chose to build a company focused on some of the toughest challenges in neuroscience. We discuss what it takes to launch a biotech in a difficult funding environment, why being scrappy and disciplined matters, and how Tenvie is balancing near-term clinical progress with continued investment in discovery.We also explore the future of neuroscience, the importance of mentorship, and where Tony believes AI and machine learning can genuinely improve drug discovery.
On this episode of the podcast we feature CEO & Co-Founder of Infinimmune, Wyatt McDonnell, to discuss a hugely impressive & milestone-rich journey since founding in 2022. Infinimmune was founded on the belief that human disease is best treated with truly human therapeutics. Their discovery platform, developed by Wyatt and his five former 10X Genomics colleagues, has already been tapped by Merck in a partnering deal potentially worth $800million plus. The first two of their immune system-derived antibodies are heading toward the clinic in Atopic Dermatitis, and the Series A round to fund those trials attracted interest from Regeneron's venture arm.On a more personal note, this episode also offers great insight into Wyatt's own journey into biotech and the entrepreneurial traits that lead to him going 'all-in' on Infinimmune. He also gives his advice for anyone in a similar position looking to go on that journey.
In this episode of The BioHub Podcast, Amber is joined by Dr. Brent Richards, Founder and CEO of 5 Prime Sciences, a company helping biotech, pharma and investors use human genetics to make better drug development decisions.Brent shares his background in clinical medicine and human genetics, the story behind 5 Prime Sciences, and how genetic evidence can help identify and validate drug targets. We explore the challenges of translating complex data into actionable insights, why understanding causal biology matters, and the opportunity to bring greater confidence to early drug discovery.
Today I’m joined by Frédéric Sweeney, President and CEO of VedaBio.Fred has spent his career at the intersection of healthcare, diagnostics, venture capital and company building. He’s also been involved with a number of companies as an investor, board member and advisor.Today, Fred is leading VedaBio, which is developing a new approach to molecular diagnostics using CRISPR. The company’s technology is designed to deliver highly accurate molecular detection much faster and closer to the point of care, with the goal of making sophisticated molecular testing much more accessible.I’m really looking forward to hearing about Fred’s journey through the industry, what he’s learned from working across startups, large diagnostics companies and venture capital, and then diving into what VedaBio is building and where he sees the future of molecular diagnostics going.
In this episode of The BioHub by Avetix, I’m joined by Steve Tregay, Managing General Partner at Mission BioCapital.Steve shares his journey across research, pharma, biotech company building and venture capital, including the story behind founding FORMA Therapeutics and the lessons that experience taught him about creating successful biotech companies.We also discuss how Mission BioCapital approaches early-stage company creation, what Steve looks for in founders and new opportunities, the role big pharma plays in the biotech ecosystem, and what he believes separates the companies that ultimately succeed from those that don’t.
In this episode of The BioHub by Avetix, I’m joined by Hans Schambye, CEO of BOOST Pharma.Hans shares what drew him to BOOST and the opportunity to develop what could become the first disease-modifying treatment for osteogenesis imperfecta. We discuss the challenge of taking a novel cell therapy from early clinical success towards Phase III, and what it takes to build the company around that journey.We also explore the lessons Hans has learned from leading and scaling multiple biotech companies, how the CEO role changes through different stages of growth, and where he sees the cell and gene therapy landscape heading next.
Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Get ready for an immersive experience into the world of biotech with The BioHub.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from The BioHub - by Avetix in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of The BioHub - by Avetix as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Max Brennan - Biotech HeadHunter.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
The BioHub - by Avetix publishes every few days. Our AI generates a summary within hours of each new episode.
The BioHub - by Avetix covers topics including Science, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.